COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
COVID-19 vaccination coverage was about 7 percentage points lower in rural counties than in urban counties as of April 10, the Centers for Disease Control and Prevention reported today.
The Food and Drug Administration updated its emergency use authorizations for two intravenous infusion therapies for outpatients at risk for progressing to severe COVID-19 disease.
The Centers for Disease Control and Prevention emphasized that its new masking recommendations for people fully vaccinated against COVID-19 do not apply to health care settings.
In a study of more than 1,800 health care workers across 33 sites in 25 U.S. states, the Pfizer and Moderna COVID-19 vaccines reduced symptomatic COVID-19 infections by 94% in fully vaccinated workers and 82% in partially vaccinated workers, the Centers for Disease Control and Prevention reported.
Adopting the advice of its Advisory Committee on Immunization Practices, the Centers for Disease Control and Prevention last night recommended the Pfizer-BioNTech vaccine for children aged 12 to 15, paving the way for providers to begin vaccinating them immediately.
The Centers for Disease Control and Prevention updated its interim guidance stating that fully vaccinated people no longer need to wear a mask or physically distance in any setting, indoors or outdoors.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine for administration in adolescents ages 12 to 15.
The Centers for Medicare & Medicaid Services released an interim final rule requiring long-term care facilities in the Medicare and Medicaid programs to offer the COVID-19 vaccine to residents and staff, educate them on the benefits and potential side effects, and begin reporting weekly COVID-…
The Food and Drug Administration announced the expansion of its emergency use authorization for Pfizer’s COVID-19 vaccine to include adolescents ages 12 to 15.
The Centers for Medicare & Medicaid Services should reconsider its decision to discontinue coverage of tele-audio services when the COVID-19 public health emergency ends, writes Blaine Greenwald, M.D., vice chair and director of geriatric psychiatry in the department of psychiatry at Zucker…